What is Diversified Healthcare Tr's earnings per share (EPS)?

Diversified Healthcare Tr (DHC) reported diluted earnings per share of $-1.19 for fiscal year 2025. This represents a 23.2% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Diversified Healthcare Tr Financials

DHC

Source SEC Filings (10-K/10-Q) Updated Dec 31, 2025 Currency USD FYE December

This page shows Diversified Healthcare Tr (DHC) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 18 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI DHC FY2025 2026-04-22

Balance-sheet shrinkage is doing more work than operations, with investing inflows funding deleveraging as revenue holds roughly steady.

In FY2025, investing cash inflow of $483.6M almost matched financing cash outflow of $492.0M, so the year’s debt reduction was funded outside the core operation. Operating cash flow fell to -$19.6M even as long-term debt dropped by $606.2M, which means the balance sheet improved faster than the business became self-funding.

Over the last two annual periods, total assets moved from $5.45B to $4.36B even as revenue stayed around the same level to slightly higher. That points to portfolio pruning rather than expansion, and return on assets was still -6.6%, so a smaller asset base has not yet translated into healthy earnings.

Interest expense eased to $204.5M from $235.2M, which helps explain why the loss margin improved even without a cash rebound. But cash on hand fell to $105.4M from $658.1M in FY2022, leaving much less liquidity cushion when operations do not cover outflows.

Financial Health Signals

Financial Profile 19/100

Based on FY2025 annual data, averaged across the last 3 years for performance metrics (most-recent year weighted highest). How this score is calculated →

Health score ≠ stock price. This rates the quality of Diversified Healthcare Tr's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Growth

Diversified Healthcare Tr's revenue grew a modest 2.8% year-over-year to $1.5B. This slow but positive growth earns a score of 41/100.

Leverage

Diversified Healthcare Tr carries a low D/E ratio of 1.47, meaning only $1.47 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 72/100, indicating a strong balance sheet with room for future borrowing.

Returns

Diversified Healthcare Tr generates a -17.2% ROE, indicating limited profit relative to shareholders' investment. This results in a returns score of 0/100. This is up from -18.9% the prior year.

Piotroski F-Score Neutral

4/9

Diversified Healthcare Tr passes 4 of 9 financial strength tests. 2 of 4 profitability signals pass, 1 of 2 leverage/liquidity signals pass, both operating efficiency signals pass.

Earnings Quality Low Quality

0.07x

For every $1 of reported earnings, Diversified Healthcare Tr generates $0.07 in operating cash flow (-$19.6M OCF vs -$285.9M net income). This low ratio suggests earnings are primarily driven by accounting accruals rather than cash generation, which may not be sustainable.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$1.5B

YoY+2.8%

5Y CAGR-1.2%

10Y CAGR+4.4%

Diversified Healthcare Tr generated $1.5B in revenue in fiscal year 2025. This represents an increase of 2.8% from the prior year.

EBITDA

N/A

Net Income

-$285.9M

YoY+22.8%

Diversified Healthcare Tr reported -$285.9M in net income in fiscal year 2025. This represents an increase of 22.8% from the prior year.

EPS (Diluted)

$-1.19

YoY+23.2%

Diversified Healthcare Tr earned $-1.19 per diluted share (EPS) in fiscal year 2025. This represents an increase of 23.2% from the prior year.

Cash & Balance Sheet

Free Cash Flow

N/A

Cash & Debt

$105.4M

YoY-27.1%

5Y CAGR+7.2%

10Y CAGR+10.8%

Diversified Healthcare Tr held $105.4M in cash against $2.4B in long-term debt as of fiscal year 2025.

Dividends Per Share

$0.04

YoY+0.0%

5Y CAGR-26.0%

10Y CAGR-30.7%

Diversified Healthcare Tr paid $0.04 per share in dividends in fiscal year 2025. This represents an increase of 0.0% from the prior year.

Shares Outstanding

242M

YoY+0.4%

5Y CAGR+0.3%

10Y CAGR+0.2%

Diversified Healthcare Tr had 242M shares outstanding in fiscal year 2025. This represents an increase of 0.4% from the prior year.

Margins & Returns

Gross Margin

N/A

Operating Margin

N/A

Net Margin

-18.6%

YoY+6.2pp

5Y CAGR-10.1pp

10Y CAGR-31.0pp

Diversified Healthcare Tr's net profit margin was -18.6% in fiscal year 2025, showing the share of revenue converted to profit. This is up 6.2 percentage points from the prior year.

Return on Equity

-17.2%

YoY+1.7pp

5Y CAGR-11.6pp

10Y CAGR-20.9pp

Diversified Healthcare Tr's ROE was -17.2% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is up 1.7 percentage points from the prior year.

Capital Allocation

R&D Spending

N/A

Share Buybacks

$1.1M

YoY+26.7%

5Y CAGR+46.3%

10Y CAGR+18.4%

Diversified Healthcare Tr spent $1.1M on share buybacks in fiscal year 2025, returning capital to shareholders by reducing shares outstanding. This represents an increase of 26.7% from the prior year.

Capital Expenditures

N/A

DHC Income Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Revenue	$1.5B+2.8%	$1.5B+6.0%	$1.4B+9.9%	$1.3B-7.2%	$1.4B-15.2%	$1.6B
Cost of Revenue	N/A	N/A	N/A	N/A	N/A	N/A
Gross Profit	N/A	N/A	N/A	N/A	N/A	N/A
R&D Expenses	N/A	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	$45.5M+71.6%	$26.5M+1.5%	$26.1M-1.1%	$26.4M-22.4%	$34.1M+11.4%	$30.6M
Operating Income	N/A	N/A	N/A	N/A	N/A	N/A
Interest Expense	$204.5M-13.1%	$235.2M+22.7%	$191.8M-8.4%	$209.4M-18.1%	$255.8M+26.9%	$201.5M
Income Tax	$1.7M+273.2%	$467K+4.9%	$445K-37.3%	$710K-50.3%	$1.4M+14.4%	$1.3M
Net Income	-$285.9M+22.8%	-$370.3M-26.1%	-$293.6M-1761.1%	-$15.8M-109.0%	$174.5M+225.1%	-$139.5M
EPS (Diluted)	$-1.19+23.2%	$-1.55-26.0%	$-1.23-1657.1%	$-0.07-109.6%	$0.73+223.7%	$-0.59

Metric	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24
Revenue	$379.6M-2.4%	$388.7M+1.6%	$382.7M-1.1%	$386.9M+1.9%	$379.6M+1.6%	$373.6M+0.6%	$371.4M+0.2%	$370.8M
Cost of Revenue	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Gross Profit	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
R&D Expenses	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	$12.5M-2.0%	$12.8M+14.4%	$11.2M+24.2%	$9.0M+822.9%	-$1.2M-108.9%	$13.9M+122.5%	$6.3M-17.3%	$7.6M
Operating Income	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Interest Expense	$46.9M-4.2%	$48.9M-4.0%	$50.9M-11.9%	$57.8M-2.8%	$59.5M+0.1%	$59.4M+1.3%	$58.7M+2.0%	$57.6M
Income Tax	$514K+52.5%	$337K-60.0%	$843K+1620.4%	$49K+228.9%	-$38K-125.7%	$148K-12.9%	$170K-9.1%	$187K
Net Income	-$21.2M+87.1%	-$164.0M-79.0%	-$91.6M-919.8%	-$9.0M+89.7%	-$87.4M+11.4%	-$98.7M-0.8%	-$97.9M-13.5%	-$86.3M
EPS (Diluted)	N/A	$-0.68-78.9%	$-0.38-850.0%	$-0.04	N/A	$-0.410.0%	$-0.41-13.9%	$-0.36

DHC Balance Sheet

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Total Assets	$4.4B-15.1%	$5.1B-5.7%	$5.4B-9.3%	$6.0B-9.4%	$6.6B+2.3%	$6.5B
Current Assets	N/A	N/A	N/A	N/A	N/A	N/A
Cash & Equivalents	$105.4M-27.1%	$144.6M-41.2%	$245.9M-62.6%	$658.1M+3.7%	$634.8M+753.1%	$74.4M
Inventory	N/A	N/A	N/A	N/A	N/A	N/A
Accounts Receivable	N/A	N/A	N/A	N/A	N/A	N/A
Goodwill	N/A	N/A	N/A	N/A	N/A	N/A
Total Liabilities	$2.7B-15.2%	$3.2B+2.2%	$3.1B-7.6%	$3.4B-15.1%	$4.0B+2.7%	$3.9B
Current Liabilities	N/A	N/A	N/A	N/A	N/A	N/A
Long-Term Debt	$2.4B-19.9%	$3.1B	N/A	N/A	N/A	N/A
Total Equity	$1.7B-15.0%	$2.0B-16.2%	$2.3B-11.4%	$2.6B-0.9%	$2.7B+6.7%	$2.5B
Retained Earnings	$1.1B-20.3%	$1.4B-20.8%	$1.8B-14.2%	$2.1B-0.8%	$2.1B+9.1%	$1.9B

Metric	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24
Total Assets	$4.4B-6.9%	$4.7B-1.5%	$4.8B-4.8%	$5.0B-2.7%	$5.1B-2.8%	$5.3B-0.9%	$5.3B-0.3%	$5.3B
Current Assets	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Cash & Equivalents	$105.4M-47.7%	$201.4M+42.0%	$141.8M-53.1%	$302.6M+109.3%	$144.6M-43.6%	$256.5M-3.4%	$265.6M+28.2%	$207.1M
Inventory	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Accounts Receivable	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Goodwill	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Total Liabilities	$2.7B-10.0%	$3.0B+3.2%	$2.9B-4.8%	$3.0B-4.1%	$3.2B-1.8%	$3.2B+1.7%	$3.2B+2.7%	$3.1B
Current Liabilities	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Long-Term Debt	$2.4B	N/A	N/A	N/A	$3.1B	N/A	N/A	N/A
Total Equity	$1.7B-1.4%	$1.7B-9.0%	$1.9B-4.8%	$1.9B-0.6%	$2.0B-4.4%	$2.0B-4.7%	$2.1B-4.4%	$2.2B
Retained Earnings	$1.1B-1.9%	$1.1B-12.5%	$1.3B-6.6%	$1.4B-0.6%	$1.4B-5.8%	$1.5B-6.2%	$1.6B-5.8%	$1.7B

DHC Cash Flow Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Operating Cash Flow	-$19.6M-117.5%	$112.2M+970.5%	$10.5M+126.0%	-$40.4M+36.3%	-$63.3M-139.9%	$158.5M
Capital Expenditures	N/A	N/A	N/A	N/A	N/A	N/A
Free Cash Flow	N/A	N/A	N/A	N/A	N/A	N/A
Investing Cash Flow	$483.6M+358.6%	-$187.0M+7.5%	-$202.1M-152.1%	$387.7M+59.8%	$242.7M+700.2%	-$40.4M
Financing Cash Flow	-$492.0M-2105.2%	-$22.3M+91.1%	-$249.7M+63.1%	-$676.0M-190.5%	$746.7M+1039.5%	-$79.5M
Dividends Paid	$9.7M+0.4%	$9.6M+0.3%	$9.6M+0.3%	$9.6M+0.3%	$9.5M-77.7%	$42.8M
Share Buybacks	$1.1M+26.7%	$904K+130.0%	$393K+129.8%	$171K-55.4%	$383K+124.0%	$171K

Metric	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24
Operating Cash Flow	-$20.1M+59.2%	-$49.3M-193.0%	$53.0M+1734.9%	-$3.2M-117.8%	$18.2M-13.9%	$21.1M-52.3%	$44.3M+54.9%	$28.6M
Capital Expenditures	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Free Cash Flow	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Investing Cash Flow	$207.4M+3291.4%	$6.1M+129.0%	-$21.1M-107.2%	$291.1M+540.1%	-$66.1M-162.5%	-$25.2M+31.6%	-$36.9M+37.4%	-$58.8M
Financing Cash Flow	-$275.1M-364.0%	$104.2M+154.8%	-$190.0M-45.0%	-$131.0M-106.0%	-$63.6M-1274.3%	-$4.6M-108.5%	$54.5M+736.4%	-$8.6M
Dividends Paid	$2.4M+0.3%	$2.4M0.0%	$2.4M0.0%	$2.4M0.0%	$2.4M+0.3%	$2.4M+0.1%	$2.4M0.0%	$2.4M
Share Buybacks	$82K-91.4%	$954K+826.2%	$103K+1616.7%	$6K+200.0%	$2K-99.7%	$781K+1716.3%	$43K-44.9%	$78K

DHC Financial Ratios

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Gross Margin	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin	N/A	N/A	N/A	N/A	N/A	N/A
Net Margin	-18.6%+6.2pp	-24.8%-3.9pp	-20.8%-19.6pp	-1.2%-13.9pp	12.6%+21.2pp	-8.5%
Return on Equity	-17.2%+1.7pp	-18.9%-6.3pp	-12.6%-12.0pp	-0.6%-7.2pp	6.6%+12.1pp	-5.6%
Return on Assets	-6.6%+0.6pp	-7.2%-1.8pp	-5.4%-5.1pp	-0.3%-2.9pp	2.6%+4.8pp	-2.1%
Current Ratio	N/A	N/A	N/A	N/A	N/A	N/A
Debt-to-Equity	1.47-0.1	1.56+0.2	1.33+0.1	1.27-0.2	1.49-0.1	1.55
FCF Margin	N/A	N/A	N/A	N/A	N/A	N/A

Metric	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24
Gross Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Net Margin	-5.6%+36.6pp	-42.2%-18.3pp	-23.9%-21.6pp	-2.3%+20.7pp	-23.0%+3.4pp	-26.4%-0.1pp	-26.4%-3.1pp	-23.3%
Return on Equity	-1.3%+8.4pp	-9.7%-4.8pp	-4.9%-4.5pp	-0.5%+4.0pp	-4.5%+0.4pp	-4.8%-0.3pp	-4.5%-0.7pp	-3.8%
Return on Assets	-0.5%+3.0pp	-3.5%-1.6pp	-1.9%-1.8pp	-0.2%+1.5pp	-1.7%+0.2pp	-1.9%-0.0pp	-1.8%-0.2pp	-1.6%
Current Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Debt-to-Equity	1.47-0.3	1.77+0.2	1.560.0	1.560.0	1.56-0.0	1.58+0.1	1.48+0.1	1.38
FCF Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Similar Companies

Global Medical GMRE

$482.4M

Sila Realty Trust Inc SILA

$1.7B

Ltc Properties LTC

$1.9B

Strawberry Field STRW

$166.8M

Universal Health UHT

$564.6M

Frequently Asked Questions

What is Diversified Healthcare Tr's annual revenue?

Diversified Healthcare Tr (DHC) reported $1.5B in total revenue for fiscal year 2025. This represents a 2.8% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Diversified Healthcare Tr's revenue growing?

Diversified Healthcare Tr (DHC) revenue grew by 2.8% year-over-year, from $1.5B to $1.5B in fiscal year 2025.

Is Diversified Healthcare Tr profitable?

No, Diversified Healthcare Tr (DHC) reported a net income of -$285.9M in fiscal year 2025, with a net profit margin of -18.6%.

How much debt does Diversified Healthcare Tr have?

As of fiscal year 2025, Diversified Healthcare Tr (DHC) had $105.4M in cash and equivalents against $2.4B in long-term debt.

What is Diversified Healthcare Tr's net profit margin?

Diversified Healthcare Tr (DHC) had a net profit margin of -18.6% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Does Diversified Healthcare Tr pay dividends?

Yes, Diversified Healthcare Tr (DHC) paid $0.04 per share in dividends during fiscal year 2025.

What is Diversified Healthcare Tr's return on equity (ROE)?

Diversified Healthcare Tr (DHC) has a return on equity of -17.2% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is Diversified Healthcare Tr's operating cash flow?

Diversified Healthcare Tr (DHC) generated -$19.6M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are Diversified Healthcare Tr's total assets?

Diversified Healthcare Tr (DHC) had $4.4B in total assets as of fiscal year 2025, including both current and long-term assets.

Does Diversified Healthcare Tr buy back shares?

Yes, Diversified Healthcare Tr (DHC) spent $1.1M on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

How many shares does Diversified Healthcare Tr have outstanding?

Diversified Healthcare Tr (DHC) had 242M shares outstanding as of fiscal year 2025.

What is Diversified Healthcare Tr's debt-to-equity ratio?

Diversified Healthcare Tr (DHC) had a debt-to-equity ratio of 1.47 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Diversified Healthcare Tr's return on assets (ROA)?

Diversified Healthcare Tr (DHC) had a return on assets of -6.6% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is Diversified Healthcare Tr's cash runway?

Based on fiscal year 2025 data, Diversified Healthcare Tr (DHC) had $105.4M in cash against an annual operating cash burn of $19.6M. This gives an estimated cash runway of approximately 64 months at the current burn rate. Cash runway measures how long a company can continue operating before running out of cash, assuming no additional funding.

What is Diversified Healthcare Tr's Piotroski F-Score?

Diversified Healthcare Tr (DHC) has a Piotroski F-Score of 4 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Diversified Healthcare Tr's earnings high quality?

Diversified Healthcare Tr (DHC) has an earnings quality ratio of 0.07x, considered low quality (accrual-driven). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

How financially healthy is Diversified Healthcare Tr?

Diversified Healthcare Tr (DHC) scores 19 out of 100 on our Financial Profile, indicating weak overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.